Physician profile
Jasmine Mitchell
NPI 1497383343
$1,243.11
in general payments reported to CMS, 2019-2025
14 companies · $640 in 2025
The $640 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $142 · 2024: $460 · 2025: $640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,243.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $310.82 | 2023-2025 | Breztri, Farxiga |
| Exact Sciences Corporation | $204.32 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $195.21 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Stryker Corporation | $157.59 | 2024 | Mako |
| Pfizer INC. | $89.07 | 2023-2025 | |
| Lilly USA, LLC | $82.71 | 2024-2025 | Mounjaro, Zepbound |
| Abbott Laboratories | $45.43 | 2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $30.23 | 2025 | Shingrix, Arexvy |
| Hologic Sales and Service, LLC | $24.87 | 2023 | Aptima, Thinprep 2000 Processor |
| Astellas Pharma US INC | $24.65 | 2025 | Veozah |
| Phathom Pharmaceuticals, INC. | $23.38 | 2024 | Voquezna |
| Optinose US, INC. | $21.31 | 2024 | |
| Inari Medical, INC. | $18.91 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $14.61 | 2025 | Otezla, Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasmine Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.